Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ADDG | Q9UEY8 | Gamma-adducin (Adducin-like protein 70) | Disease related genesHuman disease related genesPredicted intracellular proteins | Fusion and delivery mediationReceptor-signaling mediation | 16 | 0.72 | ||||
| KPCD1 | Q15139 | Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) | Disease related genesEnzymesHuman disease related genes | Solid tumour/cancerUrinary system disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 16 | 0.72 | |||
| TACD2 | P09758 | Tumor-associated calcium signal transducer 2 (Cell surface glycoprotein Trop-2) (Membrane component chromosome 1 surface marker 1) (Pancreatic carcinoma marker protein GA733-1) | Disease related genesFDA approved drug targetsHuman disease related genes | 1 | Breast cancerNon-small-cell lung cancerSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 16 | 0.72 | ||
| TGM1 | P22735 | Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1) [Cleaved into: Protein-glutamine gamma-glutamyltransferase K 67 kDa chain; Protein-glutamine gamma-glutamyltransferase K 33 kDa chain] | Disease related genesEnzymesHuman disease related genes | Autosomal Recessive Ichthyosis | Clinical-translation mediation | 16 | 0.72 | |||
| XYLT1 | Q86Y38 | Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I) (XT-I) (XylT-I) | Disease related genesEnzymesHuman disease related genes | 1 | Metabolism mediation | 16 | 0.72 | |||
| GRB7 | Q14451 | Growth factor receptor-bound protein 7 (B47) (Epidermal growth factor receptor GRB-7) (GRB7 adapter protein) | Cancer-related genesPredicted intracellular proteins | Adhesion and uptake mediationImmune mediationReceptor-signaling mediation | 15 | 0.72 | ||||
| KLC3 | Q6P597 | Kinesin light chain 3 (KLC2-like) (kinesin light chain 2) | Disease related genesEssential proteinsHuman disease related genes | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 14 | 0.72 | ||||
| RADI | P35241 | Radixin | Disease related genesHuman disease related genesPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 13 | 0.72 | ||||
| RECK | O95980 | Reversion-inducing cysteine-rich protein with Kazal motifs (hRECK) (Suppressor of tumorigenicity 15 protein) | Plasma proteinsPredicted membrane proteins | Metabolism mediationReceptor-signaling mediation | 13 | 0.72 | ||||
| S10A6 | P06703 | Protein S100-A6 (Calcyclin) (Growth factor-inducible protein 2A9) (MLN 4) (Prolactin receptor-associated protein) (PRA) (S100 calcium-binding protein A6) | Cancer-related genesPlasma proteinsPredicted intracellular proteins | Other mediation | 12 | 0.72 | ||||
| S13A3 | Q8WWT9 | Na(+)/dicarboxylate cotransporter 3 (NaDC-3) (hNaDC3) (Na(+)-coupled carboxylate transporter 3) (NaC3) (Sodium-dependent high-affinity dicarboxylate transporter 2) (Solute carrier family 13 member 3) (SLC13A3) | Disease related genesMetabolic proteinsPotential drug targets | 11 | Fusion and delivery mediation | 12 | 0.72 | |||
| SUSD2 | Q9UGT4 | Sushi domain-containing protein 2 | Predicted membrane proteins | 1 | Other mediation | 12 | 0.72 | |||
| EPS8 | Q12929 | Epidermal growth factor receptor kinase substrate 8 | Disease related genesHuman disease related genesPlasma proteins | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 11 | 0.72 | ||||
| NLGN1 | Q8N2Q7 | Neuroligin-1 | Disease related genesHuman disease related genesPotential drug targets | 1 | Adhesion and uptake mediationFusion and delivery mediation | 11 | 0.72 | |||
| SPIT1 | O43278 | Kunitz-type protease inhibitor 1 (Hepatocyte growth factor activator inhibitor type 1) (HAI-1) | Cancer-related genesEssential proteinsPlasma proteins | Receptor-signaling mediation | 11 | 0.72 | ||||
| CD14 | P08571 | Monocyte differentiation antigen CD14 (My23 antigen) (Myeloid cell-specific leucine-rich glycoprotein) (CD antigen CD14) [Cleaved into: Monocyte differentiation antigen CD14, urinary form; Monocyte differentiation antigen CD14, membrane-bound form] | Cancer-related genesCD markersHuman disease related genes | COVID-19Sepsis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 37 | 0.63 | |||
| DAF | P08174 | Complement decay-accelerating factor (CD antigen CD55) | Blood group antigen proteinsCD markersDisease related genes | Bladder cancerBrain cancerColorectal cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 34 | 0.63 | |||
| DPEP1 | P16444 | Dipeptidase 1 (EC 3.4.13.19) (Beta-lactamase) (EC 3.5.2.6) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase) (hRDP) | EnzymesFDA approved drug targetsMetabolic proteins | Bacterial infection | Clinical-translation mediationFusion and delivery mediationImmune mediation | 32 | 0.63 | |||
| CTL1 | Q8WWI5 | Choline transporter-like protein 1 (CDw92) (Solute carrier family 44 member 1) (CD antigen CD92) | CD markersDisease related genesMetabolic proteins | 9 | Fusion and delivery mediationMetabolism mediation | 31 | 0.63 | |||
| EPHA4 | P54764 | Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK) | Cancer-related genesEnzymesPlasma proteins | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 24 | 0.63 | ||
| ANXA1 | P04083 | Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35) [Cleaved into: Annexin Ac2-26] | Cancer-related genesFDA approved drug targetsPlasma proteins | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 10 | 0.63 | ||||
| GBB2 | P62879 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (G protein subunit beta-2) (Transducin beta chain 2) | Disease related genesHuman disease related genesPotential drug targets | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 10 | 0.63 | ||||
| OCLN | Q16625 | Occludin | Disease related genesHuman disease related genesPotential drug targets | 4 | Fusion and delivery mediationReceptor-signaling mediation | 10 | 0.63 | |||
| BTK | Q06187 | Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) | Cancer-related genesDisease related genesEnzymes | COVID-19Leukaemia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 9 | 0.63 | |||
| EDNRA | P25101 | Endothelin-1 receptor (Endothelin receptor type A) (ET-A) (ETA-R) (hET-AR) | Disease related genesFDA approved drug targetsG-protein coupled receptors | 7 | Anxiety disorderCardiac arrhythmiaCardiovascular disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 9 | 0.63 |